Stock data
Novartis$105.85
NOVN 
0.65% • 24 H
0.65% • 24 HDividend Yield:3.3%
Global Rank#48
Market Cap$217.57B
YTD Performance9.70%
P/E0
Revenue$46.66B
Change 7d3.55%
SP500 BenchmarkUnderperform
Country🇨🇭 Switzerland
P/S4.66
Earnings$14.85B
Dividend Yield:3.3%
Main Sector
Healthcare
Market capitalization of Novartis (NOVN)
As of July 2024, Novartis has a market cap of $217.57B. This makes Novartis the world's 48th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Novartis from 1995 to 2024
-
Value:-
Market cap history of Novartis from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $201.64B | 3.64% |
| 2023 | $194.55B | 1.53% |
| 2022 | $191.62B | 4.12% |
| 2021 | $184.03B | -4.03% |
| 2020 | $191.76B | -8.98% |
| 2019 | $210.67B | 23.70% |
| 2018 | $170.30B | 1.99% |
| 2017 | $166.98B | 11.20% |
| 2016 | $150.16B | -14.63% |
| 2015 | $175.89B | -6.01% |
| 2014 | $187.14B | 29.71% |
| 2013 | $144.28B | 23.93% |
| 2012 | $116.42B | 6.98% |
| 2011 | $108.82B | -2.27% |
| 2010 | $111.35B | -3.43% |
| 2009 | $115.30B | 7.97% |
| 2008 | $106.79B | -15.14% |
| 2007 | $125.84B | -11.60% |
| 2006 | $142.36B | 1.74% |
| 2005 | $139.93B | 20.51% |
| 2004 | $116.11B | 2.05% |
| 2003 | $113.78B | 11.30% |
| 2002 | $102.23B | -15.92% |
| 2001 | $121.59B | -16.23% |
| 2000 | $145.14B | 8.32% |
| 1999 | $133.99B | -13.41% |
| 1998 | $154.74B | 13.92% |
| 1997 | $135.82B | 61.80% |
| 1996 | $83.95B | 52.54% |
| 1995 | $55.03B | - |
NOVN Market Cap Today is $217.57B 0.65% - 6 Jul 2024
View largest stocks by market cap 
